Windtree Therapeutics, Inc.
WINT
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -162.82% | -246.19% | 200.65% | 77.14% | -217.66% |
| Total Depreciation and Amortization | 0.00% | 104.49% | -347.71% | 537.50% | 14.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5,246.92% | 101.86% | -361.57% | -119.12% | 154.99% |
| Change in Net Operating Assets | -19.45% | 84.30% | 134.63% | -236.77% | 43.53% |
| Cash from Operations | -10.39% | 34.68% | 42.82% | -177.04% | 21.07% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | -- |
| Total Debt Issued | 2,818.40% | -- | -100.00% | -87.97% | -- |
| Total Debt Repaid | -362.05% | -49.55% | 75.92% | -- | 100.00% |
| Issuance of Common Stock | -80.79% | -50.37% | -44.38% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 100.00% | 53.06% | -21.49% | -- | -- |
| Total Dividends Paid | 100.00% | 70.97% | 10.66% | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | 247.06% | 32.00% |
| Cash from Financing | 286.95% | -43.08% | -54.42% | 335.45% | 54.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -43.73% | -16.31% | -204.83% | 166.80% | 61.11% |